← Browse by Condition
Medical Condition

wound heal

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for wound heal sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — wound heal Clinical Trials

How many clinical trials are currently recruiting for wound heal?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for wound heal, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for wound heal?
wound heal research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a wound heal clinical trial?
Eligibility criteria for wound heal trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 3
1
Top Sponsors
John Elfar 1 trial
Peking University Third Hospital 1 trial
Cook Biotech Incorporated 1 trial
XenoTherapeutics, Inc. 1 trial
Isfahan University of Medical Sciences 1 trial

Recruiting Clinical Trials

NCT06333171 Phase 2
Recruiting
4-aminopyridine for Skin Wound Healing
Enrollment
150 pts
Location
United States
Sponsor
John Elfar
View Trial →
NCT06841237
Recruiting
Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management
Enrollment
56 pts
Location
China
Sponsor
Peking University Third Hospit...
View Trial →
NCT04079348
Recruiting
Oasis Donor Site Wounds Post-Market Study
Enrollment
40 pts
Location
United Kingdom
Sponsor
Cook Biotech Incorporated
View Trial →
NCT06223269 Phase 3
Recruiting
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
Enrollment
50 pts
Location
United States
Sponsor
XenoTherapeutics, Inc.
View Trial →
NCT07230223 Phase 1, Phase 2
Recruiting
Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa
Enrollment
20 pts
Location
Iran
Sponsor
Isfahan University of Medical ...
View Trial →

Related Conditions

wounds and injuries (2) wounds (1) wound of skin (1) diabetic wound (1) wound infection (1) surgical wound (1) wound (1) burns degree third (1) burn disorder (1) burn degree second (1) thermal burn (1) dystrophic epidermolysis bullosa (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology